drugset / Trial / NCT01217060

Trimodality Management of T1b Esophageal Cancers

NCT01217060

Phase 1/2 Completed 4 enrolled M.D. Anderson Cancer Center
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to learn if giving chemotherapy and radiation therapy before surgery for early-stage esophageal cancer can help to control the disease and if so, for how long. The safety of this treatment will also be studied.

Timeline

Start
2010-10
Primary completion
2020-06-14
Completion
2020-06-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Docetaxel Small molecule 20 mg/m2 Intravenous
Subject fluorouracil Small molecule 300 mg/m2 Intravenous
Background Dexamethasone Small molecule 10 mg Intravenous

Indications